Lexeo Therapeutics (LXEO) Stock Chart & Stock Price History → Crypto Pioneer Says: “The last crypto bull market has begun.” (From InvestorPlace) (Ad) Free LXEO Stock Alerts $13.85 -0.17 (-1.21%) (As of 05/17/2024 08:53 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Lexeo Therapeutics Stock Price Performance5 Day Performance-0.79%1 Month Performance+14.94%3 Month Performance-14.93%6 Month Performance+22.13%Year-To-Date Performance+3.20% Ad Stansberry ResearchGlobal crypto currency reset (41 major banks signed up)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project... Here's everything you need to know. LXEO Stock Chart for Monday, May, 20, 2024 LXEO Chart by TradingView Lexeo Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/17/2024$14.02$13.85-1.21%$14.28$13.7250,716 shs$456.22 million05/16/2024$13.96$14.02+0.43%$15.15$13.82335,730 shs$461.82 million05/15/2024$13.97$13.96-0.07%$15.00$13.7577,472 shs$459.84 million05/14/2024$13.56$13.97+3.02%$14.53$13.5977,448 shs$460.17 million05/13/2024$13.14$13.56+3.20%$13.56$12.9862,196 shs$446.67 million05/10/2024$14.50$13.14-9.38%$14.48$13.0292,011 shs$432.90 millionGlobal crypto currency reset (41 major banks signed up) (Ad)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project... Here's everything you need to know.05/09/2024$13.72$14.50+5.69%$16.79$13.44245,663 shs$477.63 million05/08/2024$13.43$13.72+2.16%$14.01$13.0856,954 shs$451.94 million05/07/2024$13.21$13.43+1.67%$13.55$12.98100,116 shs$442.38 million05/06/2024$12.77$13.21+3.45%$13.46$12.78253,428 shs$435.14 million05/03/2024$12.46$12.77+2.49%$13.11$12.6198,948 shs$420.64 million05/02/2024$12.30$12.46+1.30%$12.52$12.13162,808 shs$410.43 million05/01/2024$12.45$12.30-1.20%$12.66$12.2079,028 shs$405.16 million04/30/2024$12.30$12.45+1.22%$13.33$12.40113,579 shs$410.23 million04/29/2024$12.50$12.30-1.60%$12.97$12.00209,037 shs$405.29 million04/26/2024$12.16$12.50+2.80%$12.86$11.99377,218 shs$411.88 million04/25/2024$12.50$12.16-2.72%$12.47$11.9051,316 shs$400.65 million04/24/2024$12.14$12.50+2.97%$12.53$11.7699,355 shs$411.88 million04/23/2024$12.66$12.14-4.11%$12.79$12.1282,174 shs$400.01 million04/22/2024$12.05$12.66+5.06%$13.10$12.05229,958 shs$417.15 million04/19/2024$12.07$12.05-0.17%$12.39$11.7186,684 shs$397.05 million04/18/2024$12.26$12.07-1.55%$12.26$11.5783,451 shs$397.71 million04/17/2024$12.23$12.26+0.25%$12.49$11.8992,426 shs$403.97 million04/16/2024$12.09$12.23+1.16%$12.56$11.6578,026 shs$402.98 million04/15/2024$12.23$12.09-1.14%$12.25$11.73105,400 shs$398.37 million04/12/2024$13.06$12.23-6.36%$12.83$12.0044,755 shs$402.98 million04/11/2024$12.49$13.06+4.56%$13.13$12.2637,009 shs$348.30 million04/10/2024$13.45$12.49-7.14%$13.45$12.0096,808 shs$333.11 million04/09/2024$13.16$13.45+2.20%$15.06$12.93108,739 shs$358.71 million04/08/2024$12.99$13.16+1.31%$13.36$11.88106,819 shs$350.98 million04/05/2024$13.12$12.99-0.99%$13.38$12.7962,780 shs$346.44 million04/04/2024$14.15$13.12-7.28%$14.68$13.1157,766 shs$349.91 million04/03/2024$14.60$14.15-3.08%$14.70$14.0351,973 shs$377.38 million04/02/2024$15.85$14.60-7.89%$15.78$14.31133,162 shs$389.38 million04/01/2024$15.68$15.85+1.08%$16.02$15.0177,746 shs$422.70 million03/29/2024$15.68$15.68$15.84$15.1378,012 shs$418.19 million03/28/2024$15.27$15.68+2.69%$15.84$15.1378,012 shs$418.19 million03/27/2024$14.72$15.27+3.74%$15.41$14.6062,699 shs$407.25 million03/26/2024$14.62$14.72+0.68%$14.83$14.3948,255 shs$392.57 million03/25/2024$14.50$14.62+0.83%$15.03$14.2058,334 shs$389.92 millionBiden Nomination CANCELED? (Ad)The Hill just published that Joe Biden has received enough delegates to…“clinch the Democratic presidential nomination and all but guaranteeing he will face off against former President Trump again in November.” Why is he all BUT guaranteed the Democratic nomination, in their words?I believe I have the terrifying answer right here.03/22/2024$15.02$14.50-3.46%$15.36$14.3968,698 shs$386.72 million03/21/2024$15.15$15.02-0.86%$15.57$14.6583,739 shs$400.58 million03/20/2024$15.01$15.15+0.93%$15.49$14.5080,168 shs$404.05 million03/19/2024$15.71$15.01-4.46%$16.20$14.53119,442 shs$400.32 million03/18/2024$15.57$15.71+0.90%$15.97$14.51173,732 shs$418.99 million03/15/2024$15.68$15.57-0.70%$16.84$15.201.26 million shs$415.25 million03/14/2024$16.58$15.68-5.43%$16.94$15.03110,576 shs$417.87 million03/13/2024$15.69$16.58+5.67%$17.11$15.59147,606 shs$441.86 million03/12/2024$14.49$15.69+8.28%$16.03$14.74192,605 shs$418.08 million03/11/2024$15.13$14.49-4.23%$16.17$13.55289,466 shs$386.16 million03/08/2024$14.68$15.13+3.07%$15.41$14.6366,304 shs$403.21 million03/07/2024$14.75$14.68-0.47%$15.60$14.3756,123 shs$391.16 million03/06/2024$13.06$14.75+12.94%$15.31$13.00105,412 shs$393.09 million03/05/2024$14.73$13.06-11.34%$15.19$12.31121,484 shs$348.05 million03/04/2024$14.87$14.73-0.94%$15.20$14.1997,191 shs$392.55 million03/01/2024$14.62$14.87+1.71%$15.51$14.3856,078 shs$396.29 million02/29/2024$15.11$14.62-3.24%$16.30$14.1562,471 shs$389.62 million02/28/2024$16.36$15.11-7.64%$16.71$14.8174,902 shs$402.68 million02/27/2024$16.46$16.36-0.61%$17.11$15.6690,418 shs$435.93 million02/26/2024$15.19$16.46+8.36%$16.49$14.9555,306 shs$438.66 million02/23/2024$15.90$15.19-4.47%$16.00$15.1938,427 shs$404.81 million02/22/2024$15.43$15.90+3.05%$15.96$15.3161,420 shs$423.67 million02/21/2024$16.28$15.43-5.22%$16.35$14.9870,926 shs$411.21 million02/20/2024$15.54$16.28+4.76%$16.79$15.48148,039 shs$433.86 million02/19/2024$15.54$15.54$15.95$14.7466,400 shs$414.14 million Related Companies: Editas Medicine Stock Chart Voyager Therapeutics Stock Chart Fate Therapeutics Stock Chart iTeos Therapeutics Stock Chart C4 Therapeutics Stock Chart Taysha Gene Therapies Stock Chart Ocugen Stock Chart Alvotech Stock Chart Allogene Therapeutics Stock Chart Replimune Group Stock Chart This page (NASDAQ:LXEO) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaNext President (Not Trump. Not Biden.)The Freeport SocietyElon’s New Device is About to Shock the WorldInvestorPlace"The Biggest Drug Ever" Is ComingBehind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersDems have chosen Biden replacement?Paradigm PressBill Gates is all about this tiny $2 stockTimothy Sykes Adding Choose a watchlist: Watchlist My Default Watchlist Adding Lexeo Therapeutics, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.